ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Kronos Bio Inc

Kronos Bio Inc (KRON)

1.02
-0.02
(-1.92%)
Closed May 04 4:00PM
1.01
-0.01
(-0.98%)
After Hours: 7:55PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
1.01
Bid
1.00
Ask
1.03
Volume
299,881
0.983 Day's Range 1.06
0.731 52 Week Range 2.29
Market Cap
Previous Close
1.04
Open
1.05
Last Trade Time
Financial Volume
$ 308,257
VWAP
1.0279
Average Volume (3m)
410,791
Shares Outstanding
58,316,520
Dividend Yield
-
PE Ratio
-0.53
Earnings Per Share (EPS)
-1.93
Revenue
6.29M
Net Profit
-112.67M

About Kronos Bio Inc

Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription. Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Kronos Bio Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker KRON. The last closing price for Kronos Bio was $1.04. Over the last year, Kronos Bio shares have traded in a share price range of $ 0.731 to $ 2.29.

Kronos Bio currently has 58,316,520 shares outstanding. The market capitalization of Kronos Bio is $59.48 million. Kronos Bio has a price to earnings ratio (PE ratio) of -0.53.

KRON Latest News

Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

SAN MATEO, Calif. and CAMBRIDGE, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today...

Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2023 Financial Results

Phase 1/2 study of KB-0742 is on track to clear 80mg four-days-on, three-days-off schedule in the third quarter of 2024; topline data from expansion cohort at this schedule expected in the first...

Kronos Bio Announces Restructuring to Focus Resources on Clinical Development with Extended Cash Runway

Company to assess KB-0742 at planned new dose schedule in ongoing phase 1/2 study; topline data from expansion cohort at new dose schedule expected in the first half of 2025 IND-enabling studies...

Kronos Bio To Present Three Posters at AACR 2024 Annual Meeting

SAN MATEO, Calif. and CAMBRIDGE, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today...

Kronos Bio Announces Participation in 44th Annual Cowen Health Care Conference

SAN MATEO, Calif. and CAMBRIDGE, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.0313.166496424920.9791.060.963514681.01687283CS
4-0.21-17.21311475411.221.260.94983600.99980668CS
12-0.05-4.716981132081.061.40.94107911.08802255CS
260.1720.23809523810.841.50530.7313033181.09729419CS
52-0.6-37.26708074531.612.290.7312810771.30427199CS
156-26-96.260644205827.0128.420.7312948486.44138666CS
260-27.28-96.429833863628.2939.6050.7312847009.3899342CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BENFBeneficient
$ 6.8001
(254.17%)
31.01M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M
SHOTWSafety Shot Inc
$ 0.45
(45.16%)
644
AIPArteris Inc
$ 8.185
(38.03%)
1.11M
RGFReal Good Food Company Inc
$ 0.85
(37.32%)
4.26M
MNDRMobile health Network Solutions
$ 3.33
(-84.91%)
18.76M
NUVOHoldco Nuvo Group DG Ltd
$ 2.00
(-57.54%)
1.04M
SPTSprout Social Inc
$ 28.82
(-40.15%)
13.47M
UNITUniti Group Inc
$ 4.441
(-26.35%)
21.07M
IPDNProfessional Diversity Network Inc
$ 1.29
(-24.12%)
662.59k
AAPLApple Inc
$ 183.38
(5.98%)
163.22M
SQQQProShares UltraPro Short QQQ
$ 11.08
(-5.94%)
154.59M
JAGXJaguar Health Inc
$ 0.3164
(7.91%)
142.47M
NKLANikola Corporation
$ 0.6526
(6.55%)
106.88M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M

Your Recent History

Delayed Upgrade Clock